文献速递垂体与肾上腺疾病

原发性醛固酮增多症的盐水输注试验:免疫测定不准确性的影响

The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

该研究在5个三级中心对240例接受盐水输注试验(SIT)的患者,比较免疫测定与质谱(MS)检测血浆醛固酮的差异。Liaison和iSYS免疫测定结果分别比MS高86%和58%;以免疫测定SIT切点170 pmol/L判定为阳性的162例中,MS判定62例为非病理性。作者认为免疫测定法诊断原发性醛固酮增多症(PA)的准确性存疑,并提供了一种减少误诊的简单方法。

要点

  • Liaison和iSYS免疫测定血浆醛固酮分别比MS高86%和58%。
  • 免疫测定SIT切点170 pmol/L判定的162例阳性中,MS判定62例为非病理性。
  • 结果不一致的患者中非侧化肾上腺醛固酮产生比例高于一致患者(83% vs 28%)。

核心结论

  • 免疫测定法诊断PA在超过60%的推测双侧病变患者中有效性存疑,作者提供了一种减少免疫测定不准确相关误诊的简单方法。

研究设计与样本

  • 本研究涉及在5个三级中心接受SIT检测的240例患者,评估免疫测定与MS检测血浆醛固酮之间的不一致性。

主要发现

  • Liaison和iSYS免疫测定血浆醛固酮分别比MS高86%和58%。
  • 以免疫测定SIT切点170 pmol/L判定,78例为阴性、162例为阳性;所有阴性患者MS测定的醛固酮<117 pmol/L,低于MS切点162 pmol/L。
  • 162例免疫测定SIT阳性患者中,MS判定62例为非病理性,其中32例醛固酮<117 pmol/L。
  • 独立MS方法重复测定确认53例结果不一致患者的非病理性结果。
  • 结果不一致患者中非侧化肾上腺醛固酮产生比例高于一致患者(83% vs 28%,P < 0.0001);非侧化醛固酮产生患者中66%结果不一致。

关键数值与推荐

  • 免疫测定SIT切点:醛固酮170 pmol/L。
  • MS切点:醛固酮162 pmol/L;MS测定醛固酮<117 pmol/L视为低于切点。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Diagnosis of primary aldosteronism (PA) for many patients depends on positive results for the saline infusion test (SIT). Plasma aldosterone is often measured by immunoassays, which can return inaccurate results. OBJECTIVE: This study aimed to establish whether differences in aldosterone measurements by immunoassay versus mass spectrometry (MS) might impact confirmatory testing for PA. METHODS: This study, involving 240 patients tested using the SIT at 5 tertiary care centers, assessed discordance between immunoassay and MS-based measurements of plasma aldosterone. RESULTS: Plasma aldosterone measured by Liaison and iSYS immunoassays were respectively 86% and 58% higher than determined by MS. With an immunoassay-based SIT cutoff for aldosterone of 170 pmol/L, 78 and 162 patients had, respectivel, negative and positive results. All former patients had MS-based measurements of aldosterone < 117 pmol/L, below MS-based cutoffs of 162 pmol/L. Among the 162 patients with pathogenic SIT results, MS returned nonpathologic results in 62, including 32 under 117 pmol/L. Repeat measurements by an independent MS method confirmed nonpathogenic results in 53 patients with discordant results. Patients with discordant results showed a higher (P < 0.0001) prevalence of nonlateralized than lateralized adrenal aldosterone production than patients with concordant results (83% vs 28%). Among patients with nonlateralized aldosterone production, 66% had discordant results. Discordance was more prevalent for the Liaison than iSYS immunoassay (32% vs 16%; P = 0.0065) and was eliminated by plasma purification to remove interferents. CONCLUSION: These findings raise concerns about the validity of immunoassay-based diagnosis of PA in over 60% of patients with presumed bilateral disease. We provide a simple solution to minimize immunoassay inaccuracy-associated misdiagnosis of PA.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Eisenhofer G, Kurlbaum M, Peitzsch M, et al. The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy. J Clin Endocrinol Metab. 2022. PMID: 34963138. doi:10.1210/clinem/dgab924

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。